140 related articles for article (PubMed ID: 1983712)
1. The effect of the H2-antagonist niperotidine on intragastric acidity in healthy subjects undergoing 24-hour pH-monitoring.
Palasciano G; Maggi V; Portincasa P
Ital J Gastroenterol; 1990 Oct; 22(5):291-4. PubMed ID: 1983712
[TBL] [Abstract][Full Text] [Related]
2. Continuous intragastric pH monitoring in the evaluation of ebrotidine, cimetidine and placebo on gastric acidity in healthy volunteers.
Muñoz-Navas M; Honorato J; Reina-Ariño M; Márquez M; Herrero E; Villamayor F; Torres J; Roset PN; Fíllat O; Camps F; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):539-44. PubMed ID: 9205761
[TBL] [Abstract][Full Text] [Related]
3. Continuous intragastric pH monitoring: a real progress in the assessment of antisecretory drugs.
Savarino V
Ital J Gastroenterol; 1990; 22 Suppl 2():20-3. PubMed ID: 1983412
[TBL] [Abstract][Full Text] [Related]
4. Reduction of postprandial gastric acidity and pepsin concentration by ranitidine and antacids in healthy volunteers.
Berstad A; Rydning A; Kolstad B; Frislid K
Scand J Gastroenterol Suppl; 1981 Jun; 69():67-73. PubMed ID: 6119785
[TBL] [Abstract][Full Text] [Related]
5. Gastric acid inhibitory profile of ebrotidine, a novel H2-receptor antagonist in humans.
Maczka M; Kwiecień N; Obtułowicz W; Konturek SJ; Kamiński K; Oleksy J; Gabryelewicz A; Torres J
J Physiol Pharmacol; 1992 Jun; 43(2):139-48. PubMed ID: 1356519
[TBL] [Abstract][Full Text] [Related]
6. The new histamine H2-receptor antagonist ranitidine. Duration of action.
Dammann HG; Simon B
Scand J Gastroenterol Suppl; 1981 Jun; 69():39-43. PubMed ID: 6119781
[TBL] [Abstract][Full Text] [Related]
7. Nocturnal acid suppression with a new H2 receptor antagonist--nizatidine.
Dammann HG; Gottlieb WR; Walter TA; Dreyer M; Müller P; Simon B; Keohane P
Hepatogastroenterology; 1986 Oct; 33(5):217-20. PubMed ID: 2879782
[TBL] [Abstract][Full Text] [Related]
8. Effect of oral famotidine on 24-hour intragastric acidity.
Santana IA; Lanzon-Miller S; Pounder RE
Postgrad Med J; 1986; 62 Suppl 2():39-42. PubMed ID: 2890150
[TBL] [Abstract][Full Text] [Related]
9. Effect of Helicobacter pylori status on intragastric pH during administration of lafutidine or famotidine.
Koike T; Ohara S; Sehine H; Kawamura M; Abe Y; Inomata Y; Iijima K; Imatani A; Shimosegawa T
Hepatogastroenterology; 2007 Jun; 54(76):1280-4. PubMed ID: 17629089
[TBL] [Abstract][Full Text] [Related]
10. Addition of a H2 receptor antagonist to PPI improves acid control and decreases nocturnal acid breakthrough.
Mainie I; Tutuian R; Castell DO
J Clin Gastroenterol; 2008 Jul; 42(6):676-9. PubMed ID: 18496394
[TBL] [Abstract][Full Text] [Related]
11. The effect of ranitidine and cimetidine on the twenty-four hour intragastric acidity profile and nocturnal acid secretion in duodenal ulcer patients.
Walt RP; Malé PJ; Hunt RH; Rawlings J; Milton-Thompson GJ; Misiewicz JJ
Scand J Gastroenterol Suppl; 1981 Jun; 69():33-7. PubMed ID: 6119780
[TBL] [Abstract][Full Text] [Related]
12. The effects of 15 days of dosing with placebo, sufotidine 600 mg nocte or sufotidine 600 mg twice daily upon 24-hour intragastric acidity and 24-hour plasma gastrin.
Rogers MJ; Holmfield JH; Primrose JN; Johnston D
Aliment Pharmacol Ther; 1990; 4 Suppl 1():65-74. PubMed ID: 1983347
[TBL] [Abstract][Full Text] [Related]
13. 24-hour study of gastric acidity in normal subjects and in cholecystectomized patients using continuous pH monitoring.
Savarino V; Mela GS; Zentilin P; Sumberaz A; Bonifacino G; Gambaro P; Celle G
Hepatogastroenterology; 1991 Aug; 38(4):299-301. PubMed ID: 1937375
[TBL] [Abstract][Full Text] [Related]
14. Twenty-four-hour esophageal impedance-pH monitoring in healthy preterm neonates: rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux.
López-Alonso M; Moya MJ; Cabo JA; Ribas J; del Carmen Macías M; Silny J; Sifrim D
Pediatrics; 2006 Aug; 118(2):e299-308. PubMed ID: 16831894
[TBL] [Abstract][Full Text] [Related]
15. Effect of three single doses of oxmetidine administered intravenously on the volume and acidity of gastric secretion, serum prolactin and gastrin concentration in healthy volunteers.
Wichmann GC; Fölsch UR; von Kleist E; Hasse FM; Dillon M; Clowdus B; Creutzfeldt W
Z Gastroenterol; 1984 Jun; 22(6):285-93. PubMed ID: 6147051
[TBL] [Abstract][Full Text] [Related]
16. Reproducibility of ambulatory intragastric pH monitoring.
Baak LC; Jansen JB; Lamers CB
Neth J Med; 1993 Oct; 43(3-4):100-4. PubMed ID: 8302388
[TBL] [Abstract][Full Text] [Related]
17. [How to express results of 24-hour gastric pH measurement? Choice of a mode of expression in 27 healthy subjects].
Vallot T; Elouaer-Blanc L; Garcia del Risco F; Mignon M; Vatier J; Bonfils S
Gastroenterol Clin Biol; 1988; 12(8-9):610-8. PubMed ID: 3063573
[TBL] [Abstract][Full Text] [Related]
18. Effect of an effervescent citrate-cimetidine combination on intragastric pH in healthy subjects. A randomized, placebo-controlled three-period cross-over design.
Ducrotté P; Weber J; Colin R; Denis P
Gastroenterol Clin Biol; 1992; 16(2):162-5. PubMed ID: 1568544
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the acidity index and integrated intragastric acidity in 645 patients presenting with gastroesophageal reflux disease symptoms.
Blonski WC; Shih GL; Brensinger CM; Katzka DA; Metz DC
Scand J Gastroenterol; 2006 Apr; 41(4):382-9. PubMed ID: 16635904
[TBL] [Abstract][Full Text] [Related]
20. Influence of age and gender on gastric acid secretion as estimated by integrated acidity in patients referred for 24-hour ambulatory pH monitoring.
Shih GL; Brensinger C; Katzka DA; Metz DC
Am J Gastroenterol; 2003 Aug; 98(8):1713-8. PubMed ID: 12907323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
